Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Aug 31:2021:5573141.
doi: 10.1155/2021/5573141. eCollection 2021.

A Case of Systemic Lupus Erythematosus in a Patient Presenting with Libman-Sacks Endocarditis

Affiliations
Case Reports

A Case of Systemic Lupus Erythematosus in a Patient Presenting with Libman-Sacks Endocarditis

Mariann Al-Jehani et al. Case Rep Cardiol. .

Abstract

Background: Libman-Sacks endocarditis (LSE) is a rare cardiovascular manifestation of systemic lupus erythematosus/antiphospholipid syndrome that is described as a sterile verrucous nonbacterial vegetative lesion. These lesions can cause progressive damage to the heart valves leading to valve surgery. The most common valves to be affected are the aortic and mitral valves. Libman-Sacks endocarditis is associated with malignancies, other systemic diseases like systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome (APS). The majority of LSE patients are usually asymptomatic. Case Summary. We describe a 39-year-old male patient who presented with increasing shortness of breath and pulmonary congestion. He was found to have severe mitral valve regurgitation and mitral stenosis. Transesophageal echocardiogram confirmed the diagnosis of Libman-Sacks endocarditis with thickened mitral valve leaflets with symmetrical mass-like structure causing a restriction in the valve function during both cardiac phases later diagnosed with systemic lupus erythematosus by immunology. The patient was started on diuretics, anticoagulants, angiotensin inhibitors, beta-blockers, and hydroxychloroquine. He underwent successful mechanical mitral valve replacement with a 27 mm St. Jude valve. The mitral valve was found to be grossly thickened with friable tissue and complete amalgamation of the leaflets with subvalvular apparatus. The patient suffered some warfarin adverse effects a year later but did well otherwise.

Conclusion: This case demonstrates that Libman-Sacks endocarditis can be the first manifestation of systemic lupus erythematosus. Early and prompt diagnosis of LSE can prevent and lessen the many side effects associated with thromboembolism. Additionally, addressing the underlying disease is key to successful treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Patient's electrocardiogram showing inverted T-wave in leads II, III, and AVF.
Figure 2
Figure 2
Patient's chest X-ray demonstrating cardiomegaly and right lower lobe consolidations with pleural effusion.
Figure 3
Figure 3
Parasternal long axis view revealing a diffused leaflet thickening of the mitral valve.
Figure 4
Figure 4
Transesophageal echocardiogram showing a symmetrical mass-like structure on the ventricular surface involving the tips of both leaflets extending to the body, causing a restriction in the valve function.
Figure 5
Figure 5
Gross anatomy of the mitral valve leaflets in keeping with Libman-Sacks endocarditis.

References

    1. Moyssakis I., Tektonidou M. G., Vasilliou V. A., Samarkos M., Votteas V., Moutsopoulos H. M. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. The American Journal of Medicine. 2007;120(7):636–642. doi: 10.1016/j.amjmed.2007.01.024. - DOI - PubMed
    1. González Quintela A., Candela M. J., Vidal C., Román J., Aramburo P. Non-bacterial thrombotic endocarditis in cancer patients. Acta Cardiologica. 1991;46(1):1–9. - PubMed
    1. Roldan C. A., Sibbitt W. L., Qualls C. R., et al. Libman-Sacks endocarditis and embolic cerebrovascular disease. JACC: Cardiovascular Imaging. 2013;6(9):973–983. doi: 10.1016/j.jcmg.2013.04.012. - DOI - PMC - PubMed
    1. Doherty N. E., Siegel R. J. Cardiovascular manifestations of systemic lupus erythematosus. American Heart Journal. 1985;110(6):1257–1265. doi: 10.1016/0002-8703(85)90023-7. - DOI - PubMed
    1. Foroughi M., Hekmat M., Ghorbani M., Ghaderi H., Majidi M., Beheshti M. Mitral valve surgery in patients with systemic lupus erythematosus. The Scientific World Journal. 2014;2014:9. doi: 10.1155/2014/216291.216291 - DOI - PMC - PubMed

Publication types

LinkOut - more resources